Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review
Health disparities in breast cancer: biology meets socioeconomic status
Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines
Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells
Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells
Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor α to vinblastine and vinorelbine
Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers
A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer
ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer
Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer
Three versus six months of exercise training in breast cancer survivors
Changes in the Body Image and Relationship Scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema
Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia
XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis
E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study
Alcohol consumption and breast tumor mitochondrial DNA mutations
Coffee and tea intake and risk of breast cancer
Meta-analysis of vitamin D, calcium and the prevention of breast cancer
The association of metabolic syndrome with triple-negative breast cancer
Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1
No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2 , and GSTZ1 in breast cancer risk
Low SAFB levels are associated with worse outcome in breast cancer patients
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland
Health states of women after conservative surgery and radiation for breast cancer
Learning to predict relapse in invasive ductal carcinomas based on the subcellular localization of junctional proteins